Search
Displaying 371–380 of 645 for “retinal diseases”
-
Scientists Receive $25 Million to Develop a Vision-Restoring System that Connects to the Brain
Research NewsThe high-tech, vision-restoring system interfaces with the visual cortex, the back of the brain where visual input is processed to create the images we see.
-
Beacon Stories
People with retinal disease describe their experiences “not looking blind.”
-
Changing Someone’s Life: A New Video Emphasizes the Need to Support FFB’s Mission
Beacon StoriesAllison Corona is one of 40 people with Leber congenital amaurosis who’ve benefitted from a gene therapy clinical trial.
-
VISIONS 2014 — The Multi-Talented Dr. Shannon Boye
Research NewsDr. Boye and her research team received a $900,000 grant for a gene therapy project targeting Leber congenital amaurosis.
-
The Pseudofovea: How the Retina Adapts to Central Vision Loss
Research NewsHow the Retina Adapts to Central Vision Loss
-
Why Face Recognition Can Be Difficult with Central Vision Loss
Research NewsDiseases such as age-related macular degeneration, cone-rod dystrophy and Stargardt disease cause scotomas, or blind spots, which often have devastating effects on central vision. They cause gaps in a person’s visual field, making it difficult to see words in a book, images on a computer monitor or TV and the features of someone’s face.
-
Research News
Thanks to recent advances in stem cell research, we are getting closer to replacing cells in the retina lost to diseases such as retinitis pigmentosa and age-related macular degeneration.
-
Atsena Receives $150 Million in New Financing to Advance XLRS and Preclinical Gene Therapy Programs
Research NewsThe company has reported encouraging results from its LCA1 and XLRS gene therapy clinical trials.
-
Eye on the Cure Podcast | Episode 83: Michel Michaelides
Eye on the CureProfessor Michaelides talks about the extraordinary vision improvements for young blind children receiving gene therapy for LCA4
-
Adverum Advancing Wet AMD Gene Therapy into Phase 3 Clinical Trials
Research NewsIn earlier clinical trials, the emerging gene therapy greatly reduced the treatment burden associated with injections of approved anti-VEGF therapies.
